How does PDMI's PB Ratio compare to its peers?

Insufficient data to calculate PDMI's Price-To-Book Ratio vs. peers for valuation analysis.

How does PDMI's PB Ratio compare vs other companies in the US Medical Equipment Industry?

Insufficient data to calculate PDMI's Price-To-Book Ratio vs. industry for valuation analysis.

What is PDMI's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate PDMI's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of PDMI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate PDMI's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

PDMI Stock Overview

Develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. More details

PDMI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Latest financial reports are more than a year old

Does not have a meaningful market cap ($3K)

My Notes

Capture your thoughts, links and company narrative

Paradigm Medical Industries, Inc. Competitors

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ThermoGenesis Holdings

OTCPK:THMO

US$11.1k

Motus GI Holdings

OTCPK:MOTS

US$1.4k

ViewRay

OTCPK:VRAY.Q

US$18.3k

Price History & Performance

Summary of share price highs, lows and changes for Paradigm Medical Industries
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0002
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	0%
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	PDMI	US Medical Equipment	US Market
7D	0%	-2.1%	-2.8%
1Y	0%	9.9%	24.1%

Return vs Industry: PDMI underperformed the US Medical Equipment industry which returned 9.9% over the past year.

Return vs Market: PDMI underperformed the US Market which returned 24.5% over the past year.

Price Volatility

Is PDMI's price volatile compared to industry and market?
PDMI volatility
PDMI Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PDMI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PDMI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	n/a	n/a	www.paradigm-medical.com

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories.

Paradigm Medical Industries, Inc. Fundamentals Summary

How do Paradigm Medical Industries's earnings and revenue compare to its market cap?
PDMI fundamental statistics
Market cap	US$3.25k
Earnings (TTM)	-US$345.00k
Revenue (TTM)	US$757.00k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PDMI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PDMI income statement (TTM)
Revenue	US$757.00k
Cost of Revenue	US$228.00k
Gross Profit	US$529.00k
Other Expenses	US$874.00k
Earnings	-US$345.00k

Last Reported Earnings

Mar 31, 2012

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PDMI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 22:53
End of Day Share Price	2024/12/11 00:00
Earnings	2012/03/31
Annual Earnings	2011/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Paradigm Medical Industries, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution